RELIV INTERNATIONAL INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: RELIV INTERNATIONAL INC, 10-Q, 2000-11-14
Next: INVESTORS FIRST STAGED EQUITY L P, 10QSB, 2000-11-14



<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM FORM 10-Q
FOR THE QUARTER  ENDING  SEPTEMBER  30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFRENCE TO SUCH FORM 10-Q.

</LEGEND>
<CIK>                                          0000768710
<NAME>                          RELIV' INTERNATIONAL, INC.


<S>                             <C>
<PERIOD-TYPE>                   9-mos
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                           1,265,376
<SECURITIES>                                             0
<RECEIVABLES>                                    3,686,889
<ALLOWANCES>                                           200
<INVENTORY>                                      6,601,206
<CURRENT-ASSETS>                                12,664,836
<PP&E>                                          15,604,636
<DEPRECIATION>                                   5,296,695
<TOTAL-ASSETS>                                  24,429,502
<CURRENT-LIABILITIES>                           11,548,385
<BONDS>                                          4,981,303
                                    0
                                              0
<COMMON>                                         9,083,841
<OTHER-SE>                                      (1,814,821)
<TOTAL-LIABILITY-AND-EQUITY>                    24,429,502
<SALES>                                         47,203,270
<TOTAL-REVENUES>                                47,203,270
<CGS>                                           17,778,805
<TOTAL-COSTS>                                   27,760,848
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                 475,919
<INCOME-PRETAX>                                  1,187,698
<INCOME-TAX>                                       471,900
<INCOME-CONTINUING>                                715,798
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                       715,798
<EPS-BASIC>                                           0.07
<EPS-DILUTED>                                         0.07



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission